The World Bank today authorised $50 million in funding from the IDA (International Development Association) to increase the usage and quality of reproduction, maternal and newborn services among the poorest families.
The purpose of the “Kobikisa” Health System Project would be to offer free health treatment for specific diseases like malaria and give vaccinations free of charge. It would increase the ability of the health systems to satisfy the health care demands of the people in 36 districts, by expanding access to vital health services for around two million persons over a period of three years.
Access to basic reproductive, maternity and child health services is still a serious concern in Republic of Congo, where the high death rate might be ascribed to the low quality of treatmentsAlthough skilled birth attendants assist with almost 90 percent of infants born in healthcare facilities and maternal deaths have begun to fall in recent years, the rate is still high (378 deaths per 100,000 live births) when perceived against the Sustainable Development Goals (SDGs), the target of which is to reduce maternal mortality ratios to less than 70/ 100,000 by 2030.
“Mostly, households have to directly pay for medical services, with devastating repercussions for the weakest among them. who With this funding the Kobikisa project would provide free care and services for expecting women and children along with fee exemptions for the poorest households,” stated Abdoulaye Seck, who is the World Bank Country Director for the Democratic republic Of the Congo.
The World Bank has also agreed to support the Congolese government in the area of health, through the COVID-19 Emergency Response Project (CERP) in the amount of $11.3 million, and provide for $15 million in funding under REDISSE IV (Regional Disease Surveillance Systems Enhancement Project) (Regional Disease Surveillance Systems Enhancement Project).
The World Bank, one of the greatest providers of finance and information for developing nations, is taking wide, swift action to help developing countries adapt to the health, economic and social implications of COVID-19. This comprises $12 billion to assist middle and low income countries procure and deliver COVID-19 vaccines, testing, and treatments, and boost immunization infrastructure. The finance builds on the World Bank Group response to COVID-19 which is supporting more than 100 countries to enhance healthcare systems, assist the poorest households, and provide supporting circumstances to retain incomes and jobs for those struck hardest.